Patients who underwent bilateral treatment experienced a higher rate of clinically relevant recovery, the authors reported.

Precision BioSciences reports early PBGENE-HBV trial data showing safety and antiviral activity in chronic Hepatitis B patients, with more results expected in 2025.

Switching back from infliximab biosimilar SB2 to reference infliximab (Remicade) did not affect clinical disease activity or ...

Despite these limitations, the researchers believe the study confirmed the efficacy and safety of bimekizumab and brodalumab ...

Increased educational efforts are needed to up-skill undergraduates and postgraduates in drug safety and pharmacovigilance. Current regulatory oversight has failed to uncover important adverse ...

Baseline fracture risk for prostate cancer patients initiating long-term androgen deprivation therapy. This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers Symposium. This ...

In Robert F. Kennedy Jr.’s first interview as secretary of the Department of Health and Human Services, he made multiple ...

If you are a vaccine recipient who has been vaccinated and have experienced an AEFI, please ask your doctor, nurse practitioner, nurse, or pharmacist to complete an AEFI form on your behalf. 1a) The ...

An archived Facebook post claimed that Pfizer has released a list of side effects for COVID vaccine. The claim by the user is ...

Patients with psoriasis, psoriatic arthritis, and axial spondylarthritis using ixekizumab have a low incidence rate of cerebro-cardiovascular events.